top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
Zenflow Secures $24M in Sercies C- Funding
South San Francisco, CA, November 18, 2024 (Globe Newswire) -- Zenflow, Inc., a leader in medical device innovation for urological...
Nobias Therapeutics Appoints Patrick Dougherty as CEO to Lead Next Phase of Growth
Philadelphia, November 14, 2024 (PRNewswire) -- Nobias Therapeutics has named Patrick Dougherty as its Chief Executive Officer, marking...
Metsera Secures $215M in Series B Funding to Advance Obesity and Metabolic Disease Portfolio
New York, November 13, 2024 (Business Wire) -- Metsera has raised $215 million in Series B financing, led by Wellington Management and...
Julie Eastland Appointed CEO of Zentalis Pharmaceuticals to Lead Advancement of Azenosertib in Oncology
San Diego, CA, November 13, 2024 (Globe Newswire) -- Zentalis Pharmaceuticals has appointed Julie Eastland as CEO, supported by Ingmar...
Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio
Marlborough, MA, November 15, 2024 (PRNewswire) -- Boston Scientific has acquired Axonics for $3.7 billion, expanding its Urology...
Axonis Therapeutics Secures $115M Series A to Advance Neuromedicine Pipeline
Boston, MA, October 30, 2024 (PRNewswire) -- Axonis Therapeutics raised $115 million in Series A funding to advance AXN-027 for...
Celltex Therapeutics Welcomes Anita Perry as CEOÂ
Houston, TX, November 5, 2024 (PRNewswire) -- Celltex Therapeutics appointed Anita Perry as CEO following the retirement of Co-Founder...
Alpha-9 Oncology Secures $175M Series C to Drive Radiopharmaceutical Innovation in Cancer Treatment
Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to...
I-Mab Appoints Dr. Sean Fu as Permanent CEO to Lead Advancement of Cancer Immunotherapy Programs
Rockville, MD, November 6, 2024 (PRNewswire) -- I-Mab has named Dr. Sean Fu as its CEO to drive forward its cancer immunotherapy...
AbbVie Acquires Aliada Therapeutics for $1.4B to Expand Alzheimer's Research Portfolio
North Chicago, IL, October 28, 2024 (Reuters) -- AbbVie will acquire Aliada Therapeutics for $1.4 billion to gain access to an...
Terray Therapeutics Secures $120M in Series B Funding to Revolutionize Small Molecule Drug Development with Advanced AI
Los Angeles, CA, October 17, 2024 Â (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to...
ViaNautis Bio Appoints Dr. Adi Hoess as CEO to Propel Growth in Genetic Therapies
Cambridge, UK, October 18, 2024 ( GlobeNewswire ) -- ViaNautis Bio has appointed Dr. Adi Hoess as its new Chief Executive Officer,...
AvenCell Therapeutics Secures $112M in Series B Funding to Advance Innovative Switchable CAR-T Cell Therapies
Watertown, MA, October 22, 2024 (PRNewswire) -- AvenCell Therapeutics has secured $112 million in Series B funding to enhance its...
Mike Alvarez Appointed CEO of Glooko to Drive Growth Following $100 Million Series F Financing
Palo Alto, CA, October 10, 2024 (Business Wire) -- Mike Alvarez has been appointed as the Chief Executive Officer of Glooko, Inc.,...
Seaport Therapeutics Secures $225M in Oversubscribed Series B Financing to Propel Neuropsychiatric Drug Development
Boston, MA, October 21, 2024 (Business Wire) -- Seaport Therapeutics has raised $225 million in a Series B financing round led by...
ShiraTronics Series B Raises $66M
Minneapolis, MN, October 9, 2024 (PR Newswire) -- ShiraTronics secures $66 million in Series B financing to propel the development of...
Keith Dionne, Ph.D. Appointed CEO of Luxa Biotechnology
Fort Lee, NJ, October 1, 2024 (Business Wire) -- Dr. Keith Dionne has been appointed as the CEO of Luxa Biotechnology, where he will...
CeriBell upsizes IPO, targets $578M valuation
Fargo, ND, October 9, 2024 (Reuters) -- CeriBell is aiming for a valuation of up to $578.3 million, aiming to raise $180 million by...
Halda Therapeutics appoints Christian Schade as President and CEO to advance novel cancer therapies
New Haven, CT, October 1, 2024 (Business Wire) -- Halda Therapeutics has appointed Christian Schade as President and CEO, enhancing...
Kailera Therapeutics raises $400M to advance next-generation obesity therapies
Boston, MA , October 1, 2024 (Globe Newswire) -- Kailera Therapeutics has launched as a clinical-stage biopharmaceutical company...
bottom of page